• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Back to Resource Hub Case Study

Integrated EDC and RTSM Solutions Accelerate Phase I Oncology Trial

Signant Health
Sep 28, 2023
Case Study
When an emerging biopharmaceutical company faced tight timelines to advance their relapsed/refractory multiple myeloma treatment, they turned to Signant Biotech. Leveraging our SmartSignals Unified Platform, we enabled:
 
  • Rapid Phase I trial startup to support breakthrough therapy designation applications
  • Streamlined EDC and RTSM solutions tailored to the study’s unique oncology requirements
  • Real-time insights for enhanced patient oversight and study management
Discover how our expertise ensured timely database lock and regulatory submission readiness.

 

GET THE STORY

Similar posts

Webinar

How EDC Can Support Modern Trials

In this webinar, learn how EDC can support modern clinical trials via remote SDV, eSource collection, and integration with your wider eClinical...

Signant Health Nov 15, 2023
Brochure

Bring Your EDC Study Build In-House

Create EDC studies in-house with ease, no coding required, and leverage expert support for faster, high-quality, regulatory-ready data delivery.

Signant Health May 6, 2024

Looking for more insights? Explore related resources.

BROCHURE

A Leading EDC/DDC 
Solution
for Modern 
Clinical Trials

SEE THE BROCHURE
BLOG

RTSM: Integrated Approaches for Optimized Trial Conduct

VISIT THE BLOG
WEBINAR

How EDC Systems Can Support Modern Trials

WATCH THE WEBINAR

Get notified on new marketing insights

Here mention the benefits of subscribing